More than 50 former clients of Bell Potter Securities, including some from Perth, have launched a class action against the stockbroking firm alleging it engaged in wrongful conduct by encouraging them to invest in Progen Phamaceuticals.
02/12/2010 - 10:19
Bell Potter faces class action
02/12/2010 - 10:19
